SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-028735
Filing Date
2012-05-14
Accepted
2012-05-14 17:13:16
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v312751_10q.htm 10-Q 512398
2 EXHIBIT 3.2 v312751_ex3-2.htm EX-3.2 101716
3 EXHIBIT 31.1 v312751_ex31-1.htm EX-31.1 9909
4 EXHIBIT 31.2 v312751_ex31-2.htm EX-31.2 10135
5 EXHIBIT 32.1 v312751_ex32-1.htm EX-32.1 4179
6 EXHIBIT 32.2 v312751_ex32-2.htm EX-32.2 4067
  Complete submission text file 0001144204-12-028735.txt   1945976

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tgtxd-20120331.xml EX-101.INS 177878
8 XBRL TAXONOMY EXTENSION SCHEMA tgtxd-20120331.xsd EX-101.SCH 15210
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtxd-20120331_cal.xml EX-101.CAL 22276
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtxd-20120331_def.xml EX-101.DEF 54757
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtxd-20120331_lab.xml EX-101.LAB 121268
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtxd-20120331_pre.xml EX-101.PRE 73614
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 12839719
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences